SEC Settles Insider Trading Suit Against Ex-FDA Official
The U.S. Securities and Exchange Commission settled civil insider trading allegations Monday against a former senior U.S. Food and Drug Administration official and dropped charges against a Visium Asset Management portfolio...To view the full article, register now.
Already a subscriber? Click here to view full article